SC 13G

Company

PLUS THERAPEUTICS, INC.

Filed

February 24, 2017

Accession Number

0001564590-17-002414

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →